LETHAL
EFFECT OF
MACROMOMYCIN ON HELA CELLS
Sir: Macromomycin (MCR)'), an antitumor antibiotic, isolated from the culture filtrate of Streptomyces macromomyeeticus, is an acidic polypeptide with a molecular weight of 12,5002). It exhibited marked antitumor activity against various murine tumor systems'-4.5> In connection with its cytotoxicity, KUNIMOTO et al.g" have demonstrated that brief incubation of MCRtreated cells with proteolytic enzymes abolished MCR toxicity suggesting that the antibiotic had bound primarily to the membrane of cultured mammalian cells and interfered with their proliferation. SUZUKI et al. 7) later demonstrated that MCR caused strand scission in the DNA of cultured cells, which may result in the inhibition of mitosis and/or DNA synthesis.
The lethal effect of MCR on mammalian cells has not been characterized as yet in terms of the dose-survival and the time-inactivation relationship. This communication describes the pattern of lethal action of MCR on HeLa cells and briefly touches on its clinical implication.
HeLa S3 cells were grown in F10 medium supplemented with 10% calf serum (both components from Flow Laboratories, USA) and 0.05 heart infusion broth (Difco, USA) in a CO2 incubator at 37°C. Exponentially growing cells were dispersed with 0.1 % trypsin (1: 250, Difco) solution and 105 suspended cells were then plated into 60-mm plastic dishes. After incubating for 2 days, the cultures (2.5"-3.5 x 105 cells/dish) were treated with various concentrations of MCR for the desired period at 37°C. In two-dose experiments, the cultures were treated with MCR (0.01 ieg/ml) for 120 minutes (the 1st treatment), rinsed twice with HANKS' solution to remove the antibiotic and then the 2nd treatment at the same concentration for 60 minutes was given at intervals of 0 to 180 minutes. In this experimental procedure, the second dose is only used as a test dose to detect a possible change in the damage induced by the first (conditioning) dose.
The survival of cells was determined by the following colony formation assay. After drug exposure, the cells were rinsed twice with HANKS' solution, trypsinized and an appropriate number of cells (102-104 cells/dish) were plated in triplicate 60-mm dishes. The cultures were incubated in a CO, incubator at 37°C for 12 to 14 days for colony formation. The colonies which developed were counted after fixing and subsequent staining. Surviving fractions were obtained from the ratio of the tested group to the untreated control group. Under these conditions, the plating efficiency of the trypsin-dispersed control cells was normally 70 to 90%. MCR was prepared in our Laboratories and neocarzinostatin (NCS) was purchased from Yamanouchi Pharmaceutical Co., Tokyo. Both antibiotics were dissolved in 0.9% NaCI solution and then diluted in F10 medium supplemented with 28 mM HEPES buffer (pH 7.2) just prior to use.
The dose-survival curve of HeLa cells treated with MCR at various concentrations for 60 minutes at 37°C is shown, in comparison with cytotoxicity of NCS, in the upper panel of Fig. 1 . Both antibiotics killed the cells, in roughly exponential fashion, with increasing concentrations of the drug. The 10 percent survival dose was about 0.015 /Lg/ml for MCR and about 0.035 ,ug/ml for NCS. Therefore, the cell lethality of MCR is about 2-fold stronger than that of NCS.
Time-inactivation of the cells treated with MCR (0.01 ,ug/ml) is shown in the lower panel of Fig. 1 . The survival decreased exponentially with increasing periods of exposure for 60 minutes, then stayed essentially constant until 240 minutes. The flat region of the time-inactivation curve was not due to thermal denaturation of the drug, because 80 % of antimicrobial activity of MCR still remained after 120-minute incubation at 37°C (data not shown). To examine whether or not resistant cells induced by MCR are genetically determined, the cloned cells which were isolated from the survivors after exposure to MCR (0.01 pg/ml, 180 minutes), were tested for their sensitivity to MCR in comparison with that of untreated normal cells. As shown in Fig. 2 , the survival-response was essentially the same between normal and coloned cells, demonstrating that the progeny of the resistant cells is not genetically determined. If one assumes a discrete phase of resistance to MCR during the HeLa cell cycle, the insensitivity of the surviving cells after an exposure to After exposure of cells to the 1st dose (0.01 ug/ ml, 120 minutes) and subsequent rinsing, the 2nd dose (0.01 jig/ml, 60 minutes) was given at intervals of 0 to 180 minutes. The two-dose fractional survival is shown in the inset. The broken line indicates the single-dose survival curve obtained from Fig. 1 for reference. Each of the points and bars represents the mean ±SD of 3 experiments.
Interval between two treatments (minutes)
Time of treatiaent (minutes) the low concentration (0.01 µg/ml) of MCR may be interpreted.
To test another possibility, the two-dose fractional treatment was conducted as shown in Fig. 3 . The first dose usually reduced survival down to about 0.1 as given by broken line in Fig. 3 On the other hand, like NCS12,11) and AUR14,11) it has been demonstrated recently that MCR contains a non-protein chromophore which can be removed from the protein moiety of MCR and that the biological activity of MCR is due to its chromophore1e'17I.
They have suggested that the action of the protein moiety may be related to the permeability of the cells and stabilization of the activity of the chromophore.
Based on these findings, the additional decrease in survival by the 2nd treatment (Fig. 3) 13, 1982) 
